Ensemble Capital Management Llc increased its stake in First Rep Bk San Francisco C (FRC) by 8.66% based on its latest 2018Q1 regulatory filing with the SEC. Ensemble Capital Management Llc bought 27,775 shares as the company’s stock rose 4.55% while stock markets declined. The institutional investor held 348,626 shares of the company at the end of 2018Q1, valued at $32.29M, up from 320,851 at the end of the previous reported quarter. Ensemble Capital Management Llc who had been investing in First Rep Bk San Francisco C for a number of months, seems to be bullish on the $16.13 billion market cap company. The stock decreased 0.47% or $0.47 during the last trading session, reaching $99.59. About 1.39M shares traded or 25.10% up from the average. First Republic Bank (NYSE:FRC) has risen 7.17% since June 18, 2017 and is uptrending. It has underperformed by 5.40% the S&P500. Some Historical FRC News: 05/03/2018 – Trump’s Lawyer Complained About Not Being Reimbursed for Paying Porn Star; 05/03/2018 Two Wealth Managers Join First Republic in Boston; 16/03/2018 – First Republic Closes Above 200-Day Moving Average: Technicals; 06/03/2018 – FIRST REPUBLIC BANK FRC.N : BARCLAYS ADDS TO TOP PICK LIST; REPLACES WESTERN ALLIANCE BANCORP; 22/03/2018 – First Republic Closes Below 50-Day Moving Average: Technicals; 08/05/2018 – Moody’s assigns provisional ratings to Prime RMBS issued by Sequoia Mortgage Trust 2018-CH2; 24/05/2018 – Moody’s assigns definitive ratings to Prime RMBS issued by Sequoia Mortgage Trust 2018-CH2; 24/05/2018 – First Republic Short-Interest Ratio Rises 11% to 13 Days; 12/04/2018 – First Republic Bank Chmn and CEO Jim Herbert Appointed to Federal Reserve System’s Federal Advisory Council; 13/04/2018 – FIRST REPUBLIC BANK – INCREASED QUARTERLY CASH DIVIDEND TO $0.18 PER SHARE
Hikari Power Ltd decreased its stake in Amag Pharmaceuticals Inc (AMAG) by 45.39% based on its latest 2018Q1 regulatory filing with the SEC. Hikari Power Ltd sold 36,309 shares as the company’s stock rose 19.10% while stock markets declined. The institutional investor held 43,691 shares of the health care company at the end of 2018Q1, valued at $880,000, down from 80,000 at the end of the previous reported quarter. Hikari Power Ltd who had been investing in Amag Pharmaceuticals Inc for a number of months, seems to be less bullish one the $816.97M market cap company. The stock decreased 3.84% or $0.95 during the last trading session, reaching $23.8. About 4.53M shares traded or 477.65% up from the average. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has risen 30.22% since June 18, 2017 and is uptrending. It has outperformed by 17.65% the S&P500. Some Historical AMAG News: 04/05/2018 – AMAG AUSTRIA METALL AG AMAV.Vl – AMAG RENEWS MULTI-YEAR SUPPLY CONTRACT WITH BOEING; 05/04/2018 – AMAG Technology Releases RISK360® Incident and Case Management and Expands Product Line; 21/04/2018 – DJ AMAG Pharmaceuticals Inc, Inst Holders, 1Q 2018 (AMAG); 03/05/2018 – AMAG Pharmaceuticals 1Q Rev $146.4M; 03/05/2018 – AMAG PHARMACEUTICALS BOOSTS FORECAST FOR YEAR; 26/03/2018 – AMAG Pharmaceuticals Submits a New Drug Application to the U.S. Food and Drug Administration for Bremelanotide for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women; 26/03/2018 – Palatin Technologies Announces Submission of Bremelanotide NDA to FDA for Treatment of Hypoactive Sexual Desire Disorder (HSDD); 03/05/2018 – AMAG PHARMA 1Q ADJ REV $146.4M, EST. $150.8M; 26/03/2018 – Amag Pharma Presenting at Conference Tomorrow; 23/03/2018 – AMAG Pharmaceuticals: AMAG, Sandoz Entered Stipulation Dismissal on Settlement Agreement That Resolves Patent Litigation
Among 20 analysts covering First Republic Bank (NYSE:FRC), 9 have Buy rating, 0 Sell and 11 Hold. Therefore 45% are positive. First Republic Bank had 88 analyst reports since October 6, 2015 according to SRatingsIntel. Jefferies maintained it with “Buy” rating and $105 target in Monday, April 3 report. The firm earned “Hold” rating on Monday, December 18 by BMO Capital Markets. The firm has “Hold” rating by RBC Capital Markets given on Tuesday, October 24. The stock of First Republic Bank (NYSE:FRC) earned “Hold” rating by Keefe Bruyette & Woods on Thursday, December 21. Jefferies upgraded the shares of FRC in report on Monday, February 22 to “Buy” rating. The stock of First Republic Bank (NYSE:FRC) earned “Hold” rating by Keefe Bruyette & Woods on Wednesday, April 4. Morgan Stanley downgraded First Republic Bank (NYSE:FRC) on Wednesday, November 16 to “Equal-Weight” rating. The firm has “Mkt Perform” rating by FBR Capital given on Friday, October 14. HSBC upgraded First Republic Bank (NYSE:FRC) on Monday, February 22 to “Buy” rating. As per Tuesday, December 20, the company rating was upgraded by FBR Capital.
Ensemble Capital Management Llc, which manages about $381.11 million and $534.48M US Long portfolio, decreased its stake in First Amern Finl Corp (NYSE:FAF) by 20,421 shares to 486,914 shares, valued at $28.57M in 2018Q1, according to the filing. It also reduced its holding in Broadridge Finl Solutions In (NYSE:BR) by 98,902 shares in the quarter, leaving it with 381,412 shares, and cut its stake in Schwab Charles Corp New (NYSE:SCHW).
More recent First Republic Bank (NYSE:FRC) news were published by: Seekingalpha.com which released: “First Republic reports pricing of $300M preferred stock offering” on June 05, 2018. Also Globenewswire.com published the news titled: “Report: Developing Opportunities within Cimarex Energy, MSCI, Prestige Brand, MGM Resorts International, Discover …” on June 12, 2018. Seekingalpha.com‘s news article titled: “First Republic Bank: This 5.50% Preferred Stock Has Begun Trading On The NYSE” with publication date: June 13, 2018 was also an interesting one.
Since February 23, 2018, it had 0 insider buys, and 2 selling transactions for $516,016 activity. $500,000 worth of stock was sold by HEIDEN WILLIAM K on Monday, June 4.
More notable recent AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) news were published by: Seekingalpha.com which released: “Premarket analyst action – healthcare” on May 21, 2018, also Streetinsider.com with their article: “Pre-Open Stock Movers 06/15: (VSTM) (TXMD) (GLUU) Higher; (AFMD) (GBT) (GNK) Lower (more…)” published on June 15, 2018, Benzinga.com published: “30 Stocks Moving In Friday’s Mid-Day Session” on June 15, 2018. More interesting news about AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) were released by: Nasdaq.com and their article: “AMAG Pharmaceuticals to Present at Upcoming Investor Conference” published on May 29, 2018 as well as Nasdaq.com‘s news article titled: “AMAG Pharmaceuticals Announces Divestiture of Cord Blood Registry®” with publication date: June 15, 2018.
Hikari Power Ltd, which manages about $849.65 million US Long portfolio, upped its stake in Akari Therapeutics Plc by 485,009 shares to 636,343 shares, valued at $1.16 million in 2018Q1, according to the filing. It also increased its holding in Nestle Sa (NSRGY) by 14,140 shares in the quarter, for a total of 63,030 shares, and has risen its stake in Johnson & Johnson (NYSE:JNJ).
Investors sentiment decreased to 0.84 in 2018 Q1. Its down 0.06, from 0.9 in 2017Q4. It is negative, as 27 investors sold AMAG shares while 55 reduced holdings. 32 funds opened positions while 37 raised stakes. 37.48 million shares or 0.65% less from 37.72 million shares in 2017Q4 were reported. Bridgeway Cap Mngmt Inc reported 46,900 shares stake. Clark Estates Ny holds 0.78% or 245,000 shares in its portfolio. Qs Ltd Com reported 99,472 shares. Moreover, Macquarie Grp Inc has 0% invested in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) for 13,800 shares. Federated Invsts Inc Pa reported 0% stake. 34,401 were accumulated by Ironwood Investment Ltd Llc. 105,006 were accumulated by Guggenheim Limited Company. Citadel Advisors Ltd Liability Corp invested in 0% or 64,642 shares. Geode Cap Mgmt Limited owns 0% invested in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) for 369,556 shares. State Board Of Administration Of Florida Retirement reported 77,418 shares or 0% of all its holdings. Highland Cap Mgmt Lp holds 13,200 shares or 0.01% of its portfolio. Credit Suisse Ag reported 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Meeder Asset Management has invested 0% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Hourglass Capital Limited Liability, Texas-based fund reported 121,500 shares. Stratos Wealth Partners Limited invested in 200 shares or 0% of the stock.
Analysts await AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) to report earnings on August, 2. They expect $-0.16 EPS, up 60.00% or $0.24 from last year’s $-0.4 per share. After $-1.59 actual EPS reported by AMAG Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -89.94% EPS growth.
Among 14 analysts covering AMAG Pharmaceuticals (NASDAQ:AMAG), 3 have Buy rating, 1 Sell and 10 Hold. Therefore 21% are positive. AMAG Pharmaceuticals had 51 analyst reports since August 18, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Monday, June 26 by Cantor Fitzgerald. The company was maintained on Wednesday, August 16 by Jefferies. The stock of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) earned “Hold” rating by Cantor Fitzgerald on Monday, June 4. Cantor Fitzgerald maintained AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) rating on Wednesday, February 14. Cantor Fitzgerald has “Hold” rating and $17.0 target. The rating was maintained by Cantor Fitzgerald on Thursday, May 3 with “Hold”. As per Friday, June 15, the company rating was downgraded by Janney Capital. Raymond James downgraded the stock to “Market Perform” rating in Wednesday, May 4 report. Needham initiated the shares of AMAG in report on Thursday, October 27 with “Buy” rating. The rating was maintained by Deutsche Bank on Thursday, November 19 with “Hold”. Raymond James initiated AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) on Tuesday, September 1 with “Outperform” rating.